bluebird bio, Inc. (NASDAQ:BLUE) announced that interim data from the ongoing Phase 2/3 Starbeam Study (ALD-102) for the treatment of cerebral adrenoleukodystrophy (CALD) will be presented in an oral presentation during the Clinical Trials plenary session on April 20, 2016 at the American Academy of Neurology (AAN) 2016 Annual Meeting. The meeting is being held April 15 – 21, 2016 in Vancouver, BC, Canada.
bluebird bio, Inc. (NASDAQ:BLUE) belongs to Healthcare sector. Its weekly performance is 11.88%. On last trading day company shares ended up at $53.87. bluebird bio, Inc. (NASDAQ:BLUE) distance from 50-day simple moving average (SMA50) is 5.83%.
On 29 February, Cytokinetics, Incorporated (NASDAQ:CYTK) announced that it is joining forces with the European Organisation for Rare Diseases (EURORDIS) and the National Organization for Rare Disorders (NORD) to raise awareness of Rare Disease Day®, an international campaign dedicated to elevating the public understanding of rare diseases.
Cytokinetics, Incorporated (NASDAQ:CYTK) shares decreased -0.76% in last trading session and ended the day at $6.50. CYTK return on assets is -16.90%. Cytokinetics, Incorporated (NASDAQ:CYTK) quarterly performance is -45.38%.
Zacks Investment Research downgraded shares of PowerSecure International, Inc. (NASDAQ:POWR) from a buy rating to a hold rating in a research report sent to investors on Tuesday, Marketbeat reports.
On 03 March, PowerSecure International, Inc. (NYSE:POWR) shares remains unchanged and was closed at $18.62. POWR EPS growth in last 5 year was -38.50%. PowerSecure International, Inc. (NYSE:POWR) year to date (YTD) performance is 23.72%.
On 25 February, CBRE Group, Inc. (NYSE:CBG) announced that The Lipsey Company has named CBRE the top global brand in commercial real estate for the 15th consecutive year.
CBRE Group, Inc. (NYSE:CBG) ended the last trading day at $27.01. Company weekly volatility is calculated as 3.86% and price to cash ratio as 16.70. CBRE Group, Inc. (NYSE:CBG) showed a weekly performance of 5.06%.
On 24 February, EPAM Systems, Inc. (NYSE:EPAM) announced that Pavel Veller, CTO Digital Engagement Practice; David Mead, Sitecore Practice Lead; and Brent Pinkstaff, Solution Architect have each been named a “Most Valuable Professional (MVP)” by Sitecore, the global leader in experience management software. Pavel, David, and Brent are three of only 177 people worldwide to be named a Sitecore Technology MVP this year. There are more than 10,000 certified developers in Sitecore’s global network.
EPAM Systems, Inc. (NYSE:EPAM) shares increased 1.78% in last trading session and ended the day at $70.97. EPAM Gross Margin is 38.00% and its return on assets is 12.40%. EPAM Systems, Inc. (NYSE:EPAM) quarterly performance is -11.04%.